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Abstract.  To identify whether microtubules are in- 
volved in the maintenance of vacuolar morphology, we 
treated Saccharomyces cerevisiae with nocodazole and 
methyl benzimidazole-2-yl-carbamate, drugs which in- 
hibit the polymerization of microtubules. Treated cells 
arrest with a  single large bud in the G2/prophase por- 
tion of the cell cycle. Labeling the vacuole with either 
quinacrine or FITC-dextran revealed vacuole fragmen- 
tation that was not found in untreated cells or in cells 
arrested in G2 by unrelated means. A  drug-resistant 
mutant in beta tubulin does not show vacuolar frag- 
mentation when treated with drug.  We propose that 
microtubules are involved in the regulation of vacuole 
morphology. 
S 
INGLE copy organelles, such as the nucleus or Golgi ap- 
paratus,  must divide during each cell cycle and par- 
tition accurately into daughter cells (Warren, 1985). In 
higher eukaryotic cells the  Golgi apparatus,  endoplasmic 
reticulum, and nuclear membranes fragment at the start of 
mitosis  (Porter  and Machado,  1960; Burke ct  al.,  1982; 
Lipsky and Pagano, 1985; Zeligs and Wollman, 1979; Ger- 
ace and Blobel, 1980).  The Golgi apparatus reassembles in 
the centriolar region during telophase as the new nuclear 
membranes form (Hiller and Weber,  1982;  Burke et al., 
1982). 
There  is  substantial  evidence  that  organelle  division, 
segregation, and morphology entails interactions with cyto- 
skeletal elements. During interphase, microtubules radiate 
from the celt center throughout the cytoplasm to the cell pe- 
riphery.  In  conjunction with other  cytoskeletal elements, 
microtubules are thought to direct the spatial organization of 
organelles  (Birky,  1983).  For  example,  Golgi  interaction 
with microtubules has been shown in vivo using double im- 
munofluorescence microscopy (Rogalski and Singer,  1984). 
In vitro, organelle movement can occur on both microtubules 
and actin filaments (Schroer and Kelly, 1985). 
Mitotic cells  have  very different microtubule dynamics 
from interphase cells (Saxton et al.,  1984).  At the start of 
mitosis,  cytoplasmic microtubu!es  depolymerize  and  the 
tubulin is used to form the mitotic spindle. Since microtu- 
bules interact with organelles during interphase, the loss of 
cytoplasmic  microtubules  at  mitosis  might  facilitate or- 
ganelle division and ensure partitioning of single copy or- 
ganelles to daughter cells. When the interaction between the 
Golgi  apparatus  and  microtubules  is  disrupted  by  drug- 
induced depolymerization of microtubules,  the  Golgi ap- 
paratus  loses  its  perinuclear  organization  and  disperses 
throughout the cytoplasm (Lin and Queally, 1982; Rogalski 
and Singer,  1984).  This suggests that the Goigi fragmenta- 
tion normally seen at the start of mitosis may be caused by 
the disassembly of cytoplasmic microtubules. Using colchi- 
cine and nocodazole, Swanson et al. (1987) have shown that 
tubular lysosomal morphology is dependent on the integrity 
of cytoplasmic microtubules. 
Cell division in Saccharomyces cerevisiae and mammalian 
cells differs in several respects. Cells grow asymmetrically, 
beginning with the formation of a bud early in S phase. Cell 
surface growth is restricted to the bud (Field and Schekman, 
1980). During mitosis, the nuclear envelope does not disas- 
semble, but rather elongates across the division septum and 
divides (Byers, 1981). Little is known about the structures of 
yeast Golgi apparatus or endoplasmic reticulum during cell 
division. Yeast have a cell cycle-dependent rearrangement of 
tubulin and actin (Kilmartin and Adams,  1984).  Actin and 
beta-tubulin are encoded by single-copy genes that are essen- 
tial for cell growth (Neff et al., 1983; Shortle et al., 1982). 
Two genes encoding alpha-tubulin have been identified, as 
well as a gene encoding myosin heavy chain (Schatz et al., 
1986;  Watts et al.,  1985).  Drug-induced microtubule dis- 
ruption prevents mating-mediated nuclear fusion in S. cere- 
visiae, although cell fusion and cytoplasmic mixing occur 
normally (Delgado and Conde,  1984). 
While mammalian cells have  multiple lysosomes, yeast 
have only one or a few vacuoles throughout the cell cycle 
(Weisman et al., 1987). This raises the question of how the 
division and segregation of the vacuole is achieved and coor- 
dinated with the ceil cycle. In this paper, we describe experi- 
ments which suggest an interaction of microtubules with the 
yeast vacuole. We show that treatment of cells with microtu- 
bule-disrupting drugs causes fragmentation of the vacuole 
into many small vesicles. 
Materials and Methods 
Materials 
Nocodazole was obtained from Aldrich Chemical Co. (Milwaukee, WI), 
methyl  benzimidazole-2-yl-carbamate  (MBC) ~ from  DuPont  Co.  (Wil- 
1.  Abbreviations  used in  this paper:  DAPI, diaminophenylindole;  MBC, 
methyl benzimidazole-2-yl-carbamate. 
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(Houston, TX), and FITC-dextran (70 S), quinacrine, polyethylene imine, 
phenylenediamine, and beta-glucuronidase were from Sigma Chemical Co. 
(St.  Louis, MO). 
Drug Treatment 
Wild-type S. cerevisiae  (X2180-1A) was grown in YEPD media (Sherman 
et al.,  1974) at  30°C to early log phase. Cells were shaken with either 
nocodazole (2.5 I.tl of a 5-mg/ml stock solution in DMSO per ml of culture) 
or MBC (5/al of an 8 mg/ml stock solution in DMSO per ml of culture) 
for 2.5 h at 30°C. Control cultures were treated with the same concentra- 
tions of DMSO alone. Strains 1326 (parental) and 1323 (tub201),  obtained 
from T. Huffaker and D. Botstein (Massachusetts Institute of Technology, 
Cambridge, MA) (Thomas et al., 1985), were grown and treated with drug 
at 26°C. Strain X2180-1A-R was selected as an MBC-resistant spontaneous 
mutant on a YEPD plate with 40 p.g/ml of MBC.  UKY403 was grown at 
30°C in YEPG (Sherman et al.,  1974) and shifted to YEPD for growth 
arrest. 
Transfer of the tub2-201 Mutation 
into the X2180 Background 
Exponentially growing X2180  (MAT alpha) and DBY1323  (MAT a) were 
mated in YEPD at room temperature with gentle agitation. After 5 h, the 
cells were streaked onto a YEPD plate and zygotes were dissected with the 
use of a micromanipulator. Colonies were plated onto sporulation media 
(Sherman et al., 1974) and spores were dissected. Strains bearing the tub2- 
201  mutation were identified by the ability to grow in the presence of 40 
I.tg/ml MBC.  Subsequent matings (four) used the complementary X2180 
mating type to the strain bearing the tub2-201  mutation. 
FITC-Dextran Labeling 
Equal  volumes  of  drug-treated  cells  and  200  mg/ml  FITC-dextran 
(Makarow,  1985) with the appropriate drug concentration in YCM medium, 
pH 7.4,  (Rogers and Bussey,  1978) were mixed and incubated 30 rain at 
26°C. Cells were collected by centrifugation (30 s in a microfuge; Brinkman 
Instruments Co., Westbury,  NY.), suspended at room temperature in 1 ml 
of YCM with the appropriate drug concentration, and collected by centrifu- 
gation (30 s in a microfuge; Brinkman Instruments Co.). This procedure 
was repeated two to four times. Cells were finally suspended in 20 ktl of 
YEPD containing 1% low melting agarose with the appropriate drug con- 
centration and placed on a slide for microscopy. Alternatively, cells were 
placed on a slide coated with 0.5 mg/ml concanavalin A. 
Quinacrine Labeling 
A l-ml aliquot of drug-treated cells was centrifuged in a microfuge for 30 s. 
The ceils were resuspended in  1 ml of YEPD containing 50 mM NaH2- 
PO4,  pH  7.6, and  10  gM quinacrine.  Cells were shaken for 4.5  min at 
30°C  and  then  centrifuged  in  a  microfuge  for  30  s.  The  pellet  was 
resuspended in YEPD with  1%  low melting agarose and the appropriate 
drug concentration. 
Microscopy 
Labeled cells were observed using a Zeiss microscope (Carl Zeiss, Inc., 
Thornwood,  NY)  fitted for epifluorescence and differential interference 
contrast (or Nomarski) optics. Excitation wavelengths were 450-490  nm 
and the emission was viewed using a 520-nm cut-off filter. A Nikon F3 cam- 
era (Nikon Inc., Garden City, NY) with Kodak Tri-X-pan film was used for 
photography. Photographs were taken using a Planaplo 100×, oil-immer- 
sion objective. 
Scoring of  Cells 
Cells with a bud of  approximately the same diameter as the mother cell were 
scored for vacuolar morphology. Vacuoles were scored as single, multiple, 
or fragmented (see Fig.  1 for morphologies). 
Immunofluorescence 
Immunofluorescence  microscopy of MBC- and DMSO-treated cultures was 
performed as described by Kilmartin and Adams (1984),  with the following 
minor modifications. Formaldehyde was added to cultures without centrifu- 
gation to a final concentration of 5 % (vol/vol). The cells were permeabilized 
using 50 U  lyticase per OD6oo of cells for  10 min at 30°C.  Slides were 
pretreated with 1% polyethyleneimine for 5 rain, then rinsed ,with distilled 
water before incubation with the cells. Slides were "blocked" by incubation 
with 5 p.l of blocking buffer (1% bovine albumin, 0.05%  NP-40 in PBS) per 
sample chamber for 15 rnin, then 10 p.l of antibody was added. Antitubulin 
antibody was the generous gift of Dr. Frank Solomon (Massachusetts Insti- 
tute of Technology, Cambridge, MA). Slides were washed in 0.05 % NP-40 
in PBS, then in PBS. Blocking buffer (5 I.tl) was placed in each well. After 
10 min, secondary antibody (a 1:200 dilution of FITC-coupled goat anti- 
rabbit serum, purchased from Boehringer Mannheim Diagnostics, Inc.) was 
added. Slides were incubated in the dark for 1 h at room temperature, then 
washed as above. 
To stain the ceils with diaminophenylindole (DAPI),  10 p.I of 1-~tg/ml 
DAPI in PBS was placed in each well. Slides were incubated for 5 min in 
a light-shielded, moist chamber, then rinsed with PBS. Mounting solution 
was as in Kilmartin and Adams (1984) but without DAPI. Coverslips were 
sealed to the slides with clear nailpolish. Photographs were taken with Ko- 
dak Tri-X-pan film, ASA 400, with an 8-s exposure through a Zeiss standard 
fluorescence microscope. 
Results 
To reveal the effect of microtubule disruption on vacuolar 
morphology, early log phase cells were treated with either 
nocodazole or MBC to prevent microtubule polymerization 
(Quinlan et al.,  1980;  Pillus and Solomon, 1986;  Hasek et 
al.,  1986). These drugs specifically affect beta tubulin; each 
of 173 mutants obtained as spontaneous benomyl-resistant 
colonies mapped to the gene encoding beta tubulin (Thomas 
et al., 1985). MBC and benomyl are closely related; benomyl 
releases MBC and butyl isocyanate upon hydration (Ham- 
merschlag and Sisler, 1973). After incubation with drug for 
2.5 h, the majority of cells arrested with a single large bud. 
Cells retained their viability during the drug treatment and 
entered the cell cycle within  1 h  after drug removal. Two 
fluorescent markers were used to label the vacuoles: FITC- 
dextran, a fluorophore that labels vacuoles by diffusion (Pres- 
ton et al.,  1987), and quinacrine, a weak base that diffuses 
through membranes and concentrates in the acidic vacuole 
(Weisman et al.,  1987).  Using  these fluorescent markers, 
vacuoles were scored as single (Fig.  1, A and B), multiple 
(Fig.  1 C),  fragmented (Fig.  1,  D  and E),  or unlabeled. 
Nocodazole-treated cells  displayed  marked  vacuole  frag- 
mentation (Table I, lines I and 2). Control cells, which were 
not treated with these drugs, had a predominant morphology 
of one or a few major vacuoles and very rarely showed vacu- 
ole fragmentation. When stained with FITC-dextran, 70% 
of the vacuoles of nocodazole-treated cells were fragmented, 
while no fragmented vacuoles were found in control cultures 
(Table I,  line 2).  When labeled with quinacrine, 46%  of 
these nocodazole-treated cells showed fragmentation (Table 
I, line 1). 
Several control experiments were performed to test whether 
the fragmentation was mediated by the effect of the drug on 
microtubules.  (a)  Fragmentation  similar  to  that  in  noco- 
dazole-treated cells  was  also  seen  in  MBC-treated  cells, 
whether visualized with FITC-dextran or quinacrine (Table 
I, lines 1 and 2). (b) We obtained strain DBY 1323, which 
has  a  spontaneous point mutation  (tub2-201)  in the beta- 
tubulin gene which renders it resistant to benomyl and MBC 
(Thomas et al.,  1985).  Unlike the  isogenic parent  strain 
(DBY 1326), these cells do not arrest in the G2 phase of the 
cell cycle when treated with MBC. These cells show frag- 
mented vacuole structure in the bud (Fig. 2). We transferred 
the  tub2-201  mutation  into  our  wild-type,  drug-sensitive 
The Journal  of Cell Biology,  Volume 107,  1988  116 Figure 1. Examples of vacuole morphologies in control and drug-treated S. cerevisiae.  (A) X2180-1A cell in G2, no drug treatment, quina- 
crine stained. There are single vacuoles on each side of the doublet. (B) Strain UKY403, no drug treatment, quinacrine stained. Arrested 
by histone depletion,  it displays single vacuoles. (C) Strain X2180-1A, no drug treatment,  FITC-dextran stained.  This cell (in G2) has 
multiple vacuoles. (D) Strain X2180-1A, nocodazole treatment, FITC-dextran stained. This cell has fragmented vacuoles. (E) Strain X2180- 
1A, MBC treatment,  FITC-dextran stained.  This cell has fragmented vacuoles. Bars,  1 ~n. 
strain by successive backcrosses. The resulting strain, BGY 
1079X9,  still has a high frequency of fragmented vacuoles. 
The observation of vacuole fragmentation as a result of ge- 
netic  alteration  of beta-tubulin also  supports the  idea  that 
microtubules affect vacuole integrity. (c) Cultures of strains 
DBY 1323 and BGY 1079X9 were treated with MBC. There 
was  no  change  in  vacuole  morphology  in  these  resistant 
strains upon drug treatment (Table I, lines 4 and 5). In addi- 
tion,  we isolated an independent,  spontaneous MBC-resis- 
tant mutant of X2180-1A.  This mutant, termed X2180-1A-R, 
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Strain  Fluor 
No drug treatment  MBC treatment  Nocodazole  treatment 
Cells  Mul-  Frag-  Cells  Mul-  Frag-  Cells  Mul-  Frag- 
scored Single tiple  mented Unlabeled scored Single tiple  mented Unlabeled scored Single tiple mented Unlabeled 
n  %  %  %  %  n  %  %  %  % 
1. X2180-1A  Quinacrine  55  53  36  0  11  109  6  50  36  7 
2. X2180-1A  FITC  133  24  76  0  0  98  3  34  63  0 
3.  1326  FITC  84  1  95  4  0  96  0  48  52  0 
4.  1323  FITC  112  0  38  62  0  175  1  38  61  0 
5.  RGY1079X9  FITC  96  0  64  36  0  102  0  64  36  0 
6.  X2180-1A-R  FITC  125  1  82  17  0  171  1  83  16  0 
7.  UKY403  Quinacrine  119  95  5  0  0 
8. UKY403  FITC  70  73  27  0  0 
n  %  %  %  % 
94  21  32  46  1 
i 84  1  29  70  0 
Cells were grown to early log phase and then treated with drug or DMSO as described  in Materials  and Methods. Vacuoles  were labeled  with either quinacrine 
or FITC-dextran, then assayed for vacuole morphology  by fluorescence  light microscopy.  Morphologies  are expressed  as the percentage  of the total scored. 
showed some vacuole fragmentation in the absence of drug 
(Table I, line 6), as seen with BGY 1079X9. However, there 
was neither an arrest of cell growth nor increased vacuole 
fragmentation when these cells were treated with the drug. 
(d) A dose-response curve (Fig. 3) shows that the character- 
istic cell cycle arrest (open circles) and fragmentation (solid 
circles) occur to similar extents at each concentration of drug 
in the wild-type strain X2180-1A. (e) Immunofluorescence of 
drug-treated cells shows a complete absence of cytoplasmic 
microtubules (see below). 
To  determine whether  this  fragmented  morphology was 
simply due to an arrest in G2,  we studied the morphology 
of vacuoles in the yeast strain UKY403.  In this strain a his- 
tone H4 gene has been placed under control of the inducible 
promoter (Kim, U. J.,  P.  Kayne, and M.  Grunstein, manu- 
script in  preparation).  When  these  ceils are  shifted  from 
galactose media to glucose media, their inability to form nu- 
cleosomes during replication causes a cell cycle arrest in late 
G2/prophase. Under these conditions, the majority of vacu- 
oles (73-95 %) appear as large single organelles on each side 
of the doublet (Fig. 1 B and Table I, lines 7and 8). This ex- 
periment shows that the phenotype of vacuole fragmentation 
is neither a  property of G2 nor a  result of cell cycle arrest 
in G2. To confirm that the drugs which cause vacuole frag- 
mentation were in fact causing microtubule disruption in our 
strain,  we  examined  MBC-treated  cells (and  cells treated 
with DMSO, the solvent for the MBC) by fluorescence mi- 
croscopy,  using  antitubulin  antibody and  an  FITC  fluoro- 
phore  conjugated  to  the  second  antibody  (Fig.  4).  MBC 
treatment caused cells to arrest in G2, but disrupted the char- 
acteristic pattern of cytoplasmic microtubules seen in normal 
G2 cells (Fig. 4  A). DAPI staining confirms that the arrest 
in G2 occurs before segregation of the DNA (Fig. 4 B). As 
shown above, examination of the vacuoles of such cells by 
fluorescence microscopy (Fig. 4  C) shows the characteristic 
MBC-induced fragmentation. 
Discussion 
To  explore  the  mechanism  of  organelle  partitioning,  we 
have exploited the numerous technical advantages of study- 
Figure 2.  (A)  Strain DBY1323 (without drug)  was  stained with 
FITC-dextran. The vacuole fragmentation is restricted to the bud. 
(B) The corresponding Nomarski optics photomicrograph. Note 
that the vacuoles in the bud are too small to be readily visualized 
by Nomarski optics. Bar,  1 lain. 
80 
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Figure  3.  Strain  X2180-1A  was 
treated with the indicated concen- 
trations of MBC, as described in 
Materials and Methods. Each cell 
in random fields was scored for 
arrest in G2 (open circles) or for 
vacuole fragmentation (solid cir- 
cles). The tabulated results were 
expressed as a percentage of the 
total. 
The Journal of Cell Biology,  Volume 107, 1988  118 Figure 4. Fluorescence light microscopy of MBC-treated  or control cells. Cells were treated with MBC and DMSO, or with DMSO alone, 
as described in Materials and Methods.  (A) Immunofluorescence with antibody to tubulin.  Note the absence of  microtubules in MBC-treated 
cells,  as opposed to control cells  (1 and 2).  (B) DAPI staining  of DNA. In MBC-treated  cells,  the DNA fails to segregate  into the bud. 
(C) Vacuole morphology as visualized  by FITC-dextran labeling.  Note the fragmented  morphology of vacuoles  in drug-treated  cells. 
ing the yeast vacuole. This organelle is usually present in a 
single or low copy number,  in contrast to the lysosomes of 
higher eukaryotes. These lysosomes may associate with actin 
(Mehrabian  et al.,  1984),  and there is evidence for micro- 
tubular control of secretion and endocytosis of lysosomal en- 
zymes (von Figura et al.,  1978).  Lysosomes are present  in 
Guthrie and Wickner Yeast Vacuoles  and Microtubules  119 multiple copies (Reggio et al.,  1984), which may be suffi- 
cient to allow their partitioning to daughter cells during mito- 
sis  (Warren,  1985).  However, an extensive study of yeast 
vacuole morphology in  asynchronous cultures  has  shown 
that the most common morphology in either the mother cell 
or bud throughout the cell cycle is  1-3 vacuoles (Weisman 
et  al.,  1987).  These facts suggest  that  a  specific mecha- 
nism, different from that proposed for lysosomes, must gov- 
ern vacuolar division and segregation between parental and 
daughter cells. 
Although the morphology of the vacuole seems to remain 
constant during the cell cycle, the vacuole may, like the Golgi 
apparatus of mammalian cells, be in a continual state of flux, 
with fission and fusion of small vacuole-derived vesicles oc- 
curring throughout the  cell cycle.  Segregation of vacuole 
components into the bud  could involve transport of these 
vesicles into the developing daughter cell. Perhaps the vacu- 
ole fragmentation seen upon microtubule disruption implies 
that microtubules, or a microtubular network, are required 
for the fusion of vacuolar vesicles. Disruption of this interac- 
tion may favor the formation ofa vesiculated, or fragmented, 
vacuole structure. Nuclear fusion in yeast zygotes has also 
been shown to be inhibited in benomyl-treated cells (Delgado 
and Conde,  1984). 
While we do not know the nature of the fragmented, vacu- 
ole-related vesicles  seen upon  microtubule disruption,  at 
least three possibilities merit mention. (a) They may repre- 
sent breakdown products of vacuoles, and perhaps have no 
corresponding counterpart in  normal  cell physiology.  (b) 
They may represent, as suggested above, vesicles which nor- 
mally transit between the vacuoles of the parent cell and the 
bud, and thus be an intermediate of great interest. (c) It is 
also possible that at least some of them are endocytic vesi- 
cles. However, we have, in hundreds of drug-treated and mu- 
tant cells, never seen fragmented vacuoles in the same parent 
cell or bud with a large, intact vacuole. The loss of the large 
vacuole must  lead the vacuole membrane and contents to 
form smaller derivative vesicles. Further studies may be re- 
quired to determine the nature of these vesicles. 
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